Abstract
Haemodialysis cessation occurred simultaneously with the ily responsible for dialytic removal of solutes approxi-60 min blood draw in phase I. A final post-infusion sample mately the size of vancomycin [16] [17] [18] , corroborative was obtained immediately prior to the initiation of each clinical data are lacking. subject's subsequent dialysis session during both study arms.
The present study is an in vivo characterization of This final serum sample was obtained approximately 44 h vancomycin removal by a highly permeable cellulosic after the vancomycin infusion was administered. membrane, cellulose triacetate (CT ). In a series of
The vancomycin was infused into the drug-delivery port chronic HD patients, we correlated vancomycin on the venous dialysis tubing and all samples were obtained removal with various dialytic operating parameters in from the arterial dialysis tubing except for the intradialytic an attempt to obtain fundamental mass transfer samples. These intradialytic samples were obtained via venepuncture to obviate concerns of blood recirculation at the information. Our data indicate that vancomycin vascular access site. Therefore, no sample was obtained from removal during high-flux cellulosic dialysis is mediated the site where the vancomycin was being infused.
primarily by diffusion.
Solute concentration determinations

Subjects and methods
Serum vancomycin concentrations were assayed by use of an Enzyme Multiplied Immunoassay Technique (EMIT ),
Patients
which has interassay and intra-assay coefficients of variation of less than 7% (Syva Co., Palo Alto, CA). Samples for the Eight subjects from the Adult Outpatient Hemodialysis Unit determination of blood urea nitrogen (BUN ) concentration at the Indiana University Medical Center were enrolled in were obtained immediately before and within 5 min after the this trial. All patients were receiving chronic haemodialysis completion of dialysis in phase I. These data were used to on a thrice-weekly basis and were free of acute intercurrent calculate the normalized (single-pool ) dose of dialysis, illness. Patients with a known sensitivity to vancomycin, ( Kt/V ) urea , by the second-generation Daugirdas formula for those who had received the drug within a month prior to each patient [20] . study initiation, and those with a post-dialysis weight of less than 40 kg were excluded. The study protocol was approved by the Indiana University-Purdue University Institutional Data analysis Review Board and the Purdue University Human Subjects Committee.
Log-trapezoidal area under the curve (AUC ) data derived from the two study arms were compared using paired t tests for repeated measures. Statistical significance was considered
Haemodialysis regimen
to be P<0.05 for all comparisons. The fraction of vancomycin removed by the CT 190 dialysis study arm was calculated For the study, no changes were made in the patients' therapy using the following equation: prescription. Patients were treated with cellulose triacetate (CT 190, Baxter Healthcare Co. McGaw Park, IL) dialysers.
Fraction of dose removed=1− AUC CT dialysis study arm 0−44 hr AUC no dialysis study arm 0−44 h New (non-reprocessed ) dialysers were used in all cases. The membrane surface area of this dialyser is 1.9 m2, while the (1) membrane thickness is 15 mm. Based on the manufacturer's in vitro data obtained from experiments using an aqueous test solution, the dialyser's performance characteristics include: ultrafiltration coefficient ( K uf ) of 36 ml/h/mmHg; Results urea clearance (at a blood flow rate of 200 ml/min) 192 ml/min; and vitamin B 12 clearance (at a blood flow rate of 200 ml/min) 137 ml/min [19] . Bicarbonate dialysate and All eight subjects (mean age 51.4±9.2 y; mean±SD) dialysis machines having ultrafiltration control capability completed the trial. No adverse effects were noted in were used exclusively. Intradialytic ultrafiltration was based the study. The mean ultrafiltrate volume in the final solely on the fluid removal required for the attainment of hour of dialysis was 0.8 l. Dialysis operating conditions each patient's estimated dry weight. Information obtained were not changed throughout the entire dialysis session during each dialysis treatment included pre-and post-dialysis (blood flow rate=423±55 ml/min, dialysate flow weights, dialysate flow rate, blood flow rate, treatment dura-rate=500 ml/min, and treatment time=3.5±0.4 h).
tion, and ultrafiltration rate both for the entire treatment Based on these mean treatment parameters, diffusion and the last hour of treatment. In addition, changes in any is expected to have accounted for almost all urea of the flow rates were recorded. In phase I, subjects received a 1-g intravenous dose of vancomycin infused during the last removal [21] . Therefore, the ( Kt/V ) urea of 1.52±0.14 hour of dialysis. This vancomycin administration time was was a reflection of diffusive solute removal during the employed because the accepted practice at many American dialysis session in its entirety as well as during the last haemodialysis centres is to infuse vancomycin during the last hour when the vancomycin was administered. All hour of a haemodialysis treatment. In phase II, a 1-g dose subjects had been on HD for more than 2 years prior of vancomycin was infused intravenously over 60 min, but to study participation and had no residual renal occurred after the completion of a regularly scheduled function.
haemodialysis session (control ). A washout period of at least
The mean serum concentration vs time profile is ence that diffusion primarily mediated vancomycin removal. Of note, this analysis neglects the effect of the simultaneous presence of diffusion on convective tions from these data revealed a 26.2% (range 16-44%) solute removal. Therefore, this estimate of convective mean removal of the vancomycin dose when the drug solute removal represents a theoretical maximum value. was infused during the last hour of haemodialysis with Treatment time and membrane surface area are two the CT membrane. This AUC was significantly lower additional factors that may influence convective solute than the control group (677.0±103.7 for CT and removal to a greater extent than diffusive solute 950.2±287.3 mg/ml/h for control, respectively; removal [26, 27] . In this study, treatment time was P<0.005). During study phase I, a significant linear similar between subjects, as vancomycin dialytic clearcorrelation was observed between the percentage ance was studied only during the final hour of dialysis removed by dialysis and a measurement of diffusive for all subjects. Because CT 190 dialysers were used solute removal, expressed as ( Kt/V ) urea (r=0.88, exclusively, dialyser surface area was the same for all P<0.005; Figure 2 ). However, no significant associsubjects. Therefore, the effect of time and/or surface ation was identified between the percentage removed area on solute removal could not be evaluated in and the weight-normalized ultrafiltration rate this study. (Figure 3 ), the latter of which is a determinant of convective solute removal [16, 18] . Ultrafiltration rate was normalized to body-weight to allow for intersub-
The dialysis operating characteristics for each patient Other than conventional small solutes, such as urea were used to estimate the percentage of each dose and creatinine (MW less than 120 Da), b 2 M is the removed by diffusion and convection ( Table 1) . A only other uraemic solute whose in vivo removal by literature-derived [22] [23] [24] [25] vancomycin sieving coeffihigh-flux dialysers has been extensively studied. Several cient value of 0.8 was used to calculate the relative studies have demonstrated that transmembrane b 2 M influences of diffusion and convection in this study.
removal during high-flux dialysis is significantly reduced These estimates suggest that, within the operating by convection [28] [29] [30] . Cellulose triacetate dialysers repcharacteristics of our study, convection accounted for resent the exception to this general finding as some previous investigations involving these dialysers have demonstrated diffusion is the predominant removal mechanism [31,32]. To assess this latter finding, our group recently quantified the b 2 M diffusion characteristics of CT and another high permeability membrane, sulphonated polyacrylonitrile (PAN ) [33, 34] . Providing an explanation for the above clinical studies [31,32], our analysis showed that the b 2 M membrane diffusivity for CT was more than fivefold greater than that for PAN (3.25×10−7 cm2/s vs 0.60×10−7 cm2/s respectively). These in vitro data suggest that CT is a relatively good diffusion medium for solutes even as large as b 2 M. Recent work also has demonstrated that adsorption is a prominent b 2 M removal mechanism for certain synthetic (hydrophobic) membranes, par- Therefore, quantifying urea removal by ( Kt/V ) urea determinations provided a general estimate of diffusFor high-flux dialysis, the in vivo removal of solutes having MW between the two extremes of the low-MW ive solute removal. Our data exhibited a significant direct correlation between vancomycin removal and nitrogenous waste products and b 2 M is poorly characterized. Vancomycin is a clinically relevant solute ( Kt/V ) urea , suggesting that diffusion was primarily responsible for the drug's elimination by CT dialysers whose MW falls in this intermediate range. Laboratory studies have suggested convection is primarily respons- ( Figure 2 ). This finding was corroborated by our estimate that at least 92% of the total vancomycin ible for the removal of vitamin B 12
, a solute having a MW (1350 Da) similar to that of vancomycin, by elimination was due to diffusion ( Table 1) .
Diffusive solute removal is a function of transmemconventional [16, 17] and synthetic high-flux [37, 38] membranes. However, clinical confirmation of these brane concentration gradient. Dialysis parameters that tend to enhance these gradients are high dialysate and data has been lacking and the extensive protein binding of vitamin B 12 does not allow it to be a practical in blood flow rates and low membrane thickness [41] .
On the other hand, as solute molecular size increases, vivo marker for clearance studies.
The ability to perform detailed mass transfer ana-treatment time, ultrafiltration rate, and dialyser surface area become increasingly important determinants of lyses for vancomycin stems from a number of the drug's characteristics. First, the drug is commonly used solute removal [16, 17, 26, 27] . During the study, the time during which vancomycin removal occurred was in the ESRD population and assays for serum concentration determinations are widely available. Second, the same as the infusion period, the final hour of dialysis in all patients. Therefore the independent effect vancomycin is minimally protein-bound in patients with renal failure [39] and available to be dialysed. of time could not be analysed. In addition, no attempt was made to augment specifically the convective Finally, the drug's volume of distribution is well characterized [40] and although it has a slightly larger removal of vancomycin by employing an ultrafiltration rate greater than that required for attainment of dry range, it approximates that of urea.
An understanding of vancomycin's predominant dia-weight post-dialysis. Previous studies have demonstrated that, relative to high-flux dialysis, b 2 M removal lytic mass transfer mechanism under a given set of operating conditions, including dialyser type and flow is enhanced by the use of haemodiafiltration, which involves the purposeful use of a total ultrafiltration rates, may permit more accurate dosing of the drug to ESRD patients. However, there is a lack of information rate which greatly exceeds the net ultrafiltration requirement of the patient [21,30,42]. Finally, drug pertaining to the mass transfer characteristics of vancomycin removal by high-flux dialysers. In addition, only removal could not be correlated with dialyser surface area, which was the same (1.9 m2) for the entire patient one previous study [15] has quantified the effect of intradialytic administration of the entire vancomycin group. The amount of vancomycin infused and its infusion rate, the latter of which is analogous to dose on its simultaneous removal during high-flux dialysis. Therefore, we attempted to correlate high-flux generation rate in urea kinetic modelling, were the same in all patients (1000 mg/h), regardless of patient cellulosic removal of intradialytically administered vancomycin with dialysis-operating parameters that may size or volume of distribution. This potential problem, however, was circumvented by correlating vancomycin development of the secondary membrane before the vancomycin removal period, make this latter possibility removal with urea clearance that had been normalized to urea distribution volume. When mean ultrafiltration very unlikely. Finally, we did not explore the possibility that backfiltration or backdiffusion [21,47] influenced rates, both over the entire treatment and only during the vancomycin infusion period, were normalized in a the net removal of vancomycin. However, the clinical relevance of these phenomena has not yet been detersimilar manner, no significant correlation with vancomycin elimination was observed ( Figure 3) . These mined. In addition, previous analyses [21, 48] suggest that backfiltration would have been negligible at the results provided additional evidence that convection did not assume a significant role in vancomycin mean ultrafiltration rate (0.8 l/h) during the last hour of our study. removal by the CT membrane in this patient group.
A relationship between solute removal and outcome A final point of emphasis is that this study was performed with new (non-reused ) dialysers. Prior in chronic haemodialysis patients has only been established for small solutes [2-4]. However, recent data investigations have shown that peracetic acid-based reprocessing results in a significant decrement in b 2 M suggest that the retention of solutes in the middle molecule range may play a major role in uraemia. removal by some high-flux dialysers [42, 49] . Conversely, two recent studies have reported enhanced Using uraemic ultrafiltrate, Anderstam et al. [41] have isolated a solute, having a molecular weight b 2 M removal by high-flux polysulphone dialysers during bleach-based reprocessing [50, 51] . In a similar (1000-5000 Daltons) similar to that of vancomycin, which inhibits ingestive behaviour in rats. These recent manner, vancomycin removal may be influenced by reuse techniques. Therefore, significantly different data confirm the importance of understanding the removal mechanisms for solutes of this size during results may have been observed in this study if patients had been treated with reprocessed dialysers. high-flux dialysis.
The potential limitations associated with our experiWhile the purpose of this study was to determine the mass transfer characteristics of vancomycin, we do mental design and analysis must be considered for proper interpretation of these results. Our attempted not advocate indiscriminate use of the drug. The recent increase of vancomycin-resistant pathogens has led to correlation of vancomycin removal with factors potentially influencing convective solute removal may have recommendations for stricter vancomycin administration guidelines [52] . However, vancomycin is frebeen enhanced if dialysers of varying surface area and variable treatment times had been utilized. In addition, quently used in ESRD patients and knowledge of its mass transfer mechanisms is important to provide a similar analysis with different high-flux dialysers would have made our analysis more comprehensive. optimal care of patients receiving high-flux HD.
In summary, our findings suggest that for the specific The relatively small thickness of CT (15 mm) is one feature which distinguishes this membrane from syn-conditions of high-flux cellulosic dialysis, quantitative increases in diffusive small-solute removal (e.g. thetic high-flux membranes, which have thicknesses of 25 mm or more [5] . Because membrane diffusivity is {Kt/V} urea or urea reduction ratio) lead to a proportionally similar enhancement of vancomycin removal inversely proportional to membrane thickness [43] , diffusion may not assume the same prominent role in when the drug is infused during dialysis. Therefore, these data challenge the general concept that convecmiddle-molecule removal by the synthetic membranes. This possibility will need to be assessed in future tion is primarily responsible for the dialytic removal of solutes in the same molecular weight class as vancoinvestigations. A second potential shortcoming of this study concerns our evaluation of vancomycin removal mycin. Future studies are required to determine the applicability of these findings to other high-flux memonly during the last hour of dialysis. By this time period, the adsorbed protein layer (secondary mem-branes. In addition, future work should characterize the relative importance of diffusive and convective brane) was most probably fully developed, acting as an additional barrier to mass transfer. However, sec-mass transfer of solutes in vancomycin's size range during haemodiafiltration. ondary membrane formation has been shown to cause a significant reduction in the transmembrane removal of low-molecular-weight proteins by synthetic mem-Acknowledgements. These findings were presented in part at the 
